PA GOODDOCTOR's controlling shareholder, Anxin Limited, plans to forcibly acquire shares held by minority shareholders at a price of HKD 6.12 per share. This acquisition stems from the company's distribution of a special dividend, after which Anxin's shareholding will increase from 39.41% to 52.74%, triggering a mandatory takeover bid.The acquisition price represents a discount of 2.86% compared to the closing price of HKD 6.30 on the day before the announcement, and a discount of 1.58% compared to the average closing price over the past five trading days. Anxin has stated that there is no intention to privatize the company and has committed to maintaining the company's listing status on the Hong Kong Stock Exchange. This offer must wait for approval from...Show More

PA GOODDOCTOR's controlling shareholder, Anxin Limited, plans to forcibly acquire shares held by minority shareholders at a price of HKD 6.12 per share. This acquisition stems from the company's distribution of a special dividend, after which Anxin's shareholding will increase from 39.41% to 52.74%, triggering a mandatory takeover bid.The acquisition price represents a discount of 2.86% compared to the closing price of HKD 6.30 on the day before the announcement, and a discount of 1.58% compared to the average closing price over the past five trading days. Anxin has stated that there is no intention to privatize the company and has committed to maintaining the company's listing status on the Hong Kong Stock Exchange. This offer must wait for approval from the Hong Kong Stock Exchange after new shares are listed.The company has established an independent board committee and appointed Bafang Financial as an independent financial advisor to provide opinions on whether the offer is fair and reasonable and whether it should be accepted by independent shareholders and option holders. The comprehensive offer document is expected to be sent out within seven days after the fulfillment of the conditions precedent.